Skip to main content

COVID-19 Topic Center

Interview

Interview
Han-Zhu Qian, MD, PhD, MPH, explains the importance of screening cognitive functions and identifying the domains of cognitive impairment by age group among people living with HIV.
Interview
Michael Drummond PhD, Professor of Health Economics, University of York, UK, and Allen Lising, Managing Director of FormularyDecisions, a part of AmerisourceBergen, offer insight from their recent study which assessed the current use of cost-effectiveness analyses in decision-making for the…
Interview
Diane Smith, PhD, associate director of reimbursement…
Interview
Carmela Benson, director, real world value & evidence, Janssen Scientific Affairs, LLC, discusses recent research that examined Schizophrenia Population Health Management among adults in order to better understand how population health decision makers prioritize and respond to challenges in…
Interview
Annie Yan, PharmD, manager of value & access strategy at Xcenda, a part of AmerisourceBergen, offers insight from study that evaluated payer-initiated oncology pathways, in which trends in utilization, development, and barriers to implementation were measured.
Interview
Tasmina Hydery, PharmD, MBA, BCGP, assistant director, integrated technology solutions, and Linnea Tennant, PharmD, MBA, MS, assistant director, value and access strategy, both from Xcenda, discuss their recent study which examined the ICER value assessment framework, and its connection to trends…
Interview
Jenn Zerbato, PhD, post-doctoral research fellow, Peter Doherty Institute for Infection and Immunity, breaks down why HIV RNA could serve as a better measure of efficient latency reversal in both pre-clinical and clinical assessment of latency reversing agents.
Interview
Anthony Costello, president of Patient Cloud at Medidata, discusses challenges facing clinical trials with regard to sensor and data usage, and explores a solution that will help lower costs and enable greater operational efficiency by making it easier for patients to share data and stay enrolled…
Interview
Shephard Mpofu, MD, senior vice president and chief medical officer, Novartis Gene Therapies, discusses various trials—SPR1NT, LTFU, and RESTORE from Muscular Dystrophy Association Virtual Clinical and Scientific conference—that examined a treatment for spinal muscular atrophy (SMA), which …
Interview
Jason Ong, PhD, sexual health physician, Melbourne Sexual Health Centre, breaks down major barriers to integrating STI services in PrEP programs, including financial matters, poor access to diagnostics, and other program logistics.
Back to Top